FDA
-
-
-
-
-
-
-
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
-
-
-
-
-
-
-
InspireMD appoints Dan Dearen to board of directors
-
-
-
-
-
-
-
InspireMD launches CGuard Prime carotid stent system in US market
-
-
-
-
-
-
-
InspireMD Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
-
-
-
-
-
-
-
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
-
-
-
-
-
-
-
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuardâ„¢ Neuroprotection System
-
329,942 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

